NCT00973427已完成不适用
DNA Chip Based Prognosis of Lung Cancer
Medical Prognosis Institute A/S5 个研究点 分布在 2 个国家目标入组 144 人开始时间: 2008年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 144
- 试验地点
- 5
- 主要终点
- Disease-related survival
研究概览
简要总结
The purpose of the study is to determine whether a DNA chip, designed by Medical Prognosis Institute (MPI), can provide an accurate prognosis for survival of NSCLC (adeno-, squamous and large cell lung cancer).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A histological diagnosis of primary NSCLC stage Ia
- •Surgical removal of the tumor
- •Age between 18 and 75 years
- •Ability to understand and the willingness to sign a written informed consent document.
排除标准
- •A primary NSCLC stage Ia diagnosis that is changed to not primary NSCLC or NSCLC stage Ib-IV after surgery.
- •Adjuvant treatment with chemotherapy.
- •Prior history of cancer in the past 5 years or breast cancer at any time.
- •Life expectancy less than 3 years in the opinion of the investigator due to concurrent illnesses.
结局指标
主要结局
Disease-related survival
时间窗: 5 years
次要结局
- Time to progression(5 years)
研究者
研究点 (5)
Loading locations...
相似试验
Unknown
不适用
Circulating Tumor DNA in Surgical Lung Cancer PatientsLung NeoplasmsNCT03081741Shenzhen Gene Health Bio Tech Co., Ltd.500
招募中
不适用
Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic InterventionMetastatic Colorectal CancerNo Evidence of Disease StatusctDNA MonitoringNCT05635630Fudan University110
招募中
不适用
Biomarkers for Risk Stratification in Lung CancerNodule Solitary PulmonaryNon-small Cell Lung CancerNCT03774758University of California, San Francisco590
Unknown
不适用
Cancer Panel From Blood of Lung Cancer PatientsNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer RecurrentNCT03235765Seoul National University Hospital200
已完成
不适用
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung CancerStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the NasopharynxStage IVA Salivary Gland CancerStage IVA Squamous Cell Carcinoma of the LarynxStage IVA Squamous Cell Carcinoma of the Lip and Oral CavityStage IVA Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage IVA Verrucous Carcinoma of the LarynxStage IVA Verrucous Carcinoma of the Oral CavityStage IVB Salivary Gland CancerStage IVB Squamous Cell Carcinoma of the LarynxStage IVB Squamous Cell Carcinoma of the Lip and Oral CavityStage IVB Squamous Cell Carcinoma of the OropharynxStage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage IVB Verrucous Carcinoma of the LarynxStage IVB Verrucous Carcinoma of the Oral CavityStage IVC Salivary Gland CancerStage IVC Squamous Cell Carcinoma of the LarynxStage IVC Squamous Cell Carcinoma of the Lip and Oral CavityStage IVC Squamous Cell Carcinoma of the OropharynxStage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage IVC Verrucous Carcinoma of the LarynxStage IVC Verrucous Carcinoma of the Oral CavityTongue CancerUntreated Metastatic Squamous Neck Cancer With Occult PrimaryNCT02245100Sidney Kimmel Cancer Center at Thomas Jefferson University130